Exportiamo.it

Investor wealth has diminished by nearly Rs 14 lakh crore in the last year when Sensex scaled its record peak and has fallen by almost 18 per cent since then. Markets have seen extreme weakness due to various factors, including global economic slowdown fears, worries related to Chinese economy etc.

Taking forward the government’s resolve to crack down on black money, Finance Minister Arun Jaitley unveiled the Income Declaration Scheme.

Govt expects rise in FDI inflow to India owing to its attempts to liberalise trade and promote ease of doing business

The group claimed that it is a first for any foreign aerospace and defence original equipment manufacturer in India

Rupee hedge business already migrated to Singapore, Dubai

With Prime Minister Shinzo Abe’s Cabinet expected to approve a set of bills related to the Trans-Pacific Partnership agreement, the stage is set in the Diet for a debate on the controversial 12-nation deal. Now, adding to the national political debate will be local economic projections on how the TPP ...

The dollar traded in a narrow range around ¥113.70 in Tokyo trading on Monday, with investors refraining from active trading due to the lack of major trading pegs. At 5 p.m., the dollar stood at ¥113.71-71, down from ¥113.87-91 at the same time Friday. The euro was at $1.0968-0968, up ...

Stocks snapped their four-session winning streak on the Tokyo Stock Exchange Monday, due chiefly to profit-taking following the recent surge amid a halt to the yen’s weakening, notably against the dollar. The 225-issue Nikkei average lost 103.46 points, or 0.61 percent, to end at 16,911.32. On Friday, the key market ...

Bank of Japan Gov. Haruhiko Kuroda said Monday that the impact of a sales tax increase scheduled for April 2017 would be much less than that which resulted from the hike in 2014 — sending Japan into a recession. “The effect of the sales tax hike will be about a ...

Ten years ago, representatives from Japan’s Ono Pharmaceutical Co. went from hospital to hospital, attempting to convince doctors to test a new product under development: drugs that helped the body’s immune system fight cancer. But nobody would listen. Immunotherapy was another fad, they were told. The treatment probably offered no ...